Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Ophthalmol ; 265: 165-175, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38710352

RESUMO

PURPOSE: The optimal management of pediatric traumatic macular holes (TMH) is unclear from lack of prospective randomized trials. The literature is divided into early (≤1month post-trauma), delayed (>1 month) pars plana vitrectomy (PPV), and observation. Our aim is to find which group can achieve best-superior spectacle corrected visual acuity (VA), visual gain, and time for hole closure. DESIGN: Systematic review. METHODS: This systematic review was registered with PROSPERO (ID:CRD42022383134). The databases searched from inception until July 31, 2023, were MEDLINE OVID, Scopus, Web of Science, Embase, and Google Scholar. The articles were screened for title and abstract then for full text. Risk of bias was also assessed. Three outcome measures were analyzed: final VA, visual gain, and time to closure of macular hole (MH). MH size was divided into small (≤250 µm), medium (>250-500 µm), and large (>500 µm). RESULTS: Ninety eight (98) studies with 234 patients in the PPV group and 87 patients in the observation group were included in the review. Final VA (logarithm of the minimum angle of resolution) and visual gain were respectively in PPV vs observation groups: (1) small MH 0.37 ± 0.52 vs 0.42 ± 0.56 (P = .484) and -0.96 ± 0.83 vs -0.49 ± 0.40 (P = .005); (2) medium MH 0.58 ± 0.39 vs 0.34 ± 0.34 (P = .06) and -0.36 ± 0.42 vs -0.74 ± 0.44 (P < .001); (3) large MH 0.62 ± 0.42 vs 0.59 ± 0.35 (P = .337) and -0.31 ± 0.48 vs -0.62 ± 0.37 (P = .11). Small TMH had comparable closure time: 3.21 ± 2.52 months vs 3.49 ± 4.43 (P = .954) in the PPV and observation groups. Early and late PPV yielded comparable final VA 0.67 ± 0.66 vs 0.54 ± 0.35 (P = .576) and visual gain -0.58 ± 0.69 vs -0.49 ± 0.48 (P = .242) in the PPV and observation groups. CONCLUSIONS: PPV was very effective in closing TMH and VA gain in children throughout a wide range of hole size. Early and delayed PPV yielded similar anatomic and visual results. Observation and PPV yielded comparable final VA and closure time. Clinicians can choose either early PPV or delayed PPV when healing biomarkers are absent on periodic optical coherence tomography.


Assuntos
Traumatismos Oculares , Macula Lutea , Perfurações Retinianas , Vitrectomia , Adolescente , Criança , Humanos , Traumatismos Oculares/fisiopatologia , Traumatismos Oculares/cirurgia , Traumatismos Oculares/diagnóstico , Perfurações Retinianas/cirurgia , Perfurações Retinianas/fisiopatologia , Perfurações Retinianas/diagnóstico , Tomografia de Coerência Óptica , Acuidade Visual/fisiologia , Vitrectomia/métodos , Macula Lutea/lesões
2.
Ocul Oncol Pathol ; 10(1): 9-14, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38751496

RESUMO

Introduction: We aim to explore the safety and efficacy of episcleral brachytherapy as a primary management option for eyes with retinal pigment epithelial (RPE) adenoma. Methods: Retrospective chart review of the demographic, clinical, ancillary, and postoperative outcome data of patients with RPE adenoma in 2 tertiary referral centers. Tumor regression, final visual acuity, and complications were assessed. Results: Five patients (3 females and 2 males) were included. Four of the 5 eyes had peripheral and mid-peripheral lesions, while one tumor was juxtapapillary. Three eyes were treated with ruthenium-106 (100 Gray), and 2 received iodine-125 episcleral plaques (85 Gray). All eyes showed clinical and imaging-based evidence of regression. Four eyes had stable or improved visual acuity, while 1 eye exhibited one line loss of visual acuity due to radiation retinopathy. Local recurrence was not observed in any eye over a median follow-up of 24 (range 6-112) months. Conclusions: Episcleral brachytherapy is an effective management option for select cases of RPE adenoma that is capable of achieving tumor regression while maintaining favorable visual acuity. The initial safety profile of brachytherapy is good without significant vision-compromising complications.

3.
Clin Ophthalmol ; 15: 2263-2277, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34103890

RESUMO

PURPOSE: We aimed to identify the risk factors that may predispose preterm neonates to develop aggressive posterior retinopathy of prematurity (APROP). METHODS: This retrospective case control study included 16 infants with APROP in zone 1 or posterior zone 2. Thirty-four gestational age and birth weight-matched controls with stage 2 or less ROP were included. We reviewed medical records on infant birth and postnatal characteristics. RESULTS: Patients who developed APROP had a significantly longer duration of caffeine therapy, were significantly more likely to be small for gestational age (SGA), and were more likely to have a positive blood culture than patients who developed less severe ROP. Patients with APROP who required retreatment had received inotropes for a longer duration of time, had received more plasma transfusions, were more likely to have IVH, and had a greater decrease in the serum hemoglobin during hospitalization. CONCLUSION: Being SGA, receiving caffeine for a longer duration, and having culture-proven sepsis were associated with APROP. IVH, a low serum hemoglobin, the need for more plasma transfusions, and a longer duration of inotropes were associated with APROP which required retreatment.

4.
Eur J Ophthalmol ; 30(4): 730-737, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30977377

RESUMO

PURPOSE: The aim of this study was to investigate the diagnostic value of a topical prednisolone acetate 1% provocative test for steroid-induced ocular hypertension before intravitreal triamcinolone acetonide injection. METHODS: This is a prospective, single-center, randomized controlled study at Kasr El Aini Hospital, Cairo University. Patients scheduled for intravitreal triamcinolone acetonide were enrolled and randomly allocated in a ratio 2:1 to either Group A: received prednisolone acetate provocative test and those who did not develop SIOH proceeded with intravitreal triamcinolone acetonide or Group B: did not receive prednisolone acetate provocative test and proceeded directly to intravitreal triamcinolone acetonide. Intraocular pressures were measured weekly for 4 weeks following intravitreal triamcinolone acetonide. Steroid-induced ocular hypertension is defined as intraocular pressure increase of 5 mmHg or more from baseline after prednisolone acetate provocative test or intravitreal triamcinolone acetonide. RESULTS: A total of 66 eyes (66 patients) were included. Of which, 10 eyes (23.8%) showed prednisolone acetate provocative test steroid-induced ocular hypertension during the 4-week period. Intravitreal triamcinolone acetonide steroid-induced ocular hypertension was less likely to develop in Group A (prednisolone acetate provocative test non-steroid-induced ocular hypertension, n = 32, 31.25%) than in group B (n = 24, 54.2%) (p = 0.006, odds ratio: 0.178, 95% CI: 0.53-0.596). Our test achieved a negative predictive value of 68.75%. CONCLUSION: The topical prednisolone acetate provocative test may be a useful method to predict a steroid-induced ocular hypertension following intravitreal triamcinolone acetonide.


Assuntos
Glucocorticoides/uso terapêutico , Pressão Intraocular/efeitos dos fármacos , Edema Macular/tratamento farmacológico , Hipertensão Ocular/diagnóstico , Prednisolona/análogos & derivados , Oclusão da Veia Retiniana/tratamento farmacológico , Triancinolona Acetonida/uso terapêutico , Administração Oftálmica , Adulto , Idoso , Anti-Inflamatórios/administração & dosagem , Feminino , Humanos , Injeções Intravítreas , Edema Macular/etiologia , Masculino , Pessoa de Meia-Idade , Hipertensão Ocular/induzido quimicamente , Soluções Oftálmicas , Prednisolona/administração & dosagem , Estudos Prospectivos , Oclusão da Veia Retiniana/complicações
7.
J Clin Pathol ; 58(1): 102-3, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15623496

RESUMO

A 13 year old girl presented with recurrent painful "varicosities" on her right calf. These lesions were subsequently clinically diagnosed as "cavernous haemangiomas" after normal duplex scanning and were excised. Histological examination revealed multiple glomangiomas (glomus tumours). A literature review revealed only two reported cases of nodular multiple glomangioma, so that this is the third case to be reported in the literature.


Assuntos
Tumor Glômico/congênito , Neoplasias Primárias Múltiplas/congênito , Neoplasias de Tecidos Moles/congênito , Adolescente , Diagnóstico Diferencial , Feminino , Tumor Glômico/patologia , Hemangioma Cavernoso/diagnóstico , Humanos , Perna (Membro) , Neoplasias Primárias Múltiplas/patologia , Neoplasias de Tecidos Moles/patologia
8.
J Endocrinol ; 175(1): 225-32, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12379507

RESUMO

Regulation of cardiovascular system activity involves complex interactions amongst numerous factors. Three of these vasoactive factors are adrenomedullin, C-type natriuretic peptide (CNP) and endothelin-1 (ET-1), each of which is claimed to have important local effects. To investigate paracrine/autocrine regulation of the secretion of these peptides we used a cell immunoblot method. We postulated that basal release of adrenomedullin and CNP by endothelial cells is modulated by ET-1. Dispersed human aortic endothelial cells were attached to a protein binding membrane and incubated for 1 or 4 h with control medium or with ET-1, endothelin receptor antagonists or antibody to ET-1, and then submitted to immunohistochemical staining. Peptides (adrenomedullin, CNP and ET-1) within individual cells were stained, as was peptide secreted and adjacent to the cell. It was demonstrated that adrenomedullin, CNP and ET-1 can be contained within the same cell. In addition, we observed that individual endothelial cells can secrete all three peptides. The endothelin ET-A/ET-B receptor antagonist, bosentan, the ET-B receptor antagonist, BQ-788, and anti-ET-1 serum decreased the percentage of endothelial cells that secreted adrenomedullin and CNP relative to control. Conversely, the addition of ET-1 induced an increase in the number of endothelial cells that secreted adrenomedullin and CNP. These results provide strong evidence that endogenous ET-1, from human vascular endothelial cells, acts in a paracrine/autocrine manner to modulate the basal release of adrenomedullin and CNP. Our observations of this modulation suggest that vascular endothelial cells of humans constitute an important component of a self-responsive vasoregulatory system.


Assuntos
Endotelina-1/farmacologia , Endotélio Vascular/metabolismo , Peptídeo Natriurético Tipo C/metabolismo , Peptídeos/metabolismo , Adrenomedulina , Aorta , Bosentana , Células Cultivadas , Antagonistas dos Receptores de Endotelina , Endotelina-1/imunologia , Endotélio Vascular/efeitos dos fármacos , Humanos , Soros Imunes/farmacologia , Immunoblotting/métodos , Oligopeptídeos/farmacologia , Piperidinas/farmacologia , Sulfonamidas/farmacologia
9.
J Endocrinol ; 163(2): 345-51, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10556785

RESUMO

For full fertility in the female ovulation is necessary, which is dependent on the production of a surge of LH. An understanding of the processes which result in the high levels of LH requires delineation of the activities of individual component cells. In this study the responses of gonadotrophs to two signalling hypothalamic peptides, GnRH and oxytocin, were investigated. A cell immunoblot method was used to identify and distinguish between cells which secrete LH and those which contain LH but do not secrete the glycohormone. Rats were killed on the morning of pro-oestrus, the pituitary collected and the cells dispersed onto a protein-binding membrane for study. Cells were then incubated with GnRH and oxytocin, after which the membranes including the attached cells were stained by immunocytochemistry for LH. GnRH increased the total number of immunopositive cells which were present in a concentration-dependent manner. The most prominent change after 2 h incubation was in the number of secreting cells, whereas after 4 h there was also a marked increase in numbers of nonsecreting cells. Oxytocin also increased the total number of immunopositive cells in a concentration-responsive manner, however the profile of action of oxytocin was different from that observed for GnRH. Oxytocin had a relatively greater effect on numbers of immunopositive nonsecreting cells. Thus, the results reveal the potential for gonadotrophs to be flexibly and appropriately modulated by selected hypothalamic peptides. When cells were preincubated with oxytocin prior to GnRH there was not an additive increase in the numbers of immunopositive cells, suggesting that the two agonists act, in a nonidentical manner, on similar cells. The increase in the total number of immunopositive cells implies that there was a production of LH or post-translational processing, induced by exposure to GnRH or oxytocin. The results confirmed the heterogeneity of gonadotrophs and the existence of functionally distinguishable subpopulations, and revealed a difference between the effects of GnRH and oxytocin on expression and secretion of LH.


Assuntos
Hormônio Liberador de Gonadotropina/farmacologia , Hormônio Luteinizante/metabolismo , Ocitocina/farmacologia , Adeno-Hipófise/efeitos dos fármacos , Proestro/metabolismo , Animais , Técnicas de Cultura de Células , Relação Dose-Resposta a Droga , Interações Medicamentosas , Feminino , Adeno-Hipófise/citologia , Adeno-Hipófise/metabolismo , Ratos
10.
Haemophilia ; 5(4): 273-5, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10469183

RESUMO

Development of inhibitors is a known complication in some haemophiliacs receiving coagulation factor replacement therapy. We report on the successful management of a young boy with haemophilia A with inhibitor using recombinant factor VIIa. We had failed to control bleeding in this patient following his circumcision, despite infusion with high doses of factor VIII concentrate for 2 weeks. Recombinant factor VIIa is a useful 'factor VIII bypassing agent' for the control of bleeding in patients with haemophilia A and B who develop inhibitors. We suggest that severely affected haemophiliacs should be absolved of ritual circumcision as a protective measure against what might become a life-threatening haemorrhage - especially in those with inhibitors.


Assuntos
Fator VIII/imunologia , Fator VIIa/uso terapêutico , Hemofilia A/tratamento farmacológico , Isoanticorpos/sangue , Perda Sanguínea Cirúrgica , Criança , Circuncisão Masculina/efeitos adversos , Fator VIII/administração & dosagem , Hemofilia A/imunologia , Hemofilia A/cirurgia , Hemorragia/tratamento farmacológico , Hemorragia/etiologia , Humanos , Isoanticorpos/efeitos adversos , Kuweit , Masculino , Proteínas Recombinantes/uso terapêutico
11.
J Urol ; 161(5): 1498-500, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10210381

RESUMO

PURPOSE: Urethrorectal fistulas are rare, and the etiology is usually traumatic or iatrogenic (postoperative). Several operative approaches and techniques have been used for fistulous repair but no procedure has proved to be the best or universally acceptable. We present a new technique for repairing urethrorectal fistulas. MATERIALS AND METHODS: We successfully treated 12 male patients 7 to 65 years old who presented with urethrorectal fistula from 1990 to 1997 using the perineal subcutaneous dartos pedicled flap procedure. Urethrorectal fistulas resulted from crush pelvic injury in 6 cases and gunshot in 2, and developed after prostatectomy in 4. The fistula was associated with urethral stricture in 4 cases. A perineal approach was used in all cases of urethrorectal fistula and combined with the transsymphyseal approach in the 4 patients with posterior urethral stricture. We interposed a subcutaneous dartos pedicled flap as a vascularized tissue flap between the repaired rectum and urethra. RESULTS: The results of our technique were excellent in all cases. No leakage or perineal collection developed and there was no fistula recurrence. In 1 patient urethral stricture was managed by visual internal urethrotomy. Loss of the internal and external sphincters resulted in urinary incontinence in 4 cases, involving gunshot injury (2), crush pelvic injury (1) and prostatectomy (1). Followup ranged from 9 to 42 months. CONCLUSIONS: Our technique of a perineal subcutaneous dartos pedicled flap fulfills all principles of the successful repair of urethrorectal fistula. We consider it to be an ideal solution to this urological dilemma.


Assuntos
Fístula Retal/cirurgia , Retalhos Cirúrgicos , Doenças Uretrais/cirurgia , Fístula Urinária/cirurgia , Adolescente , Adulto , Idoso , Criança , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Períneo , Procedimentos Cirúrgicos Urológicos/métodos
12.
J Urol ; 156(3): 975-8, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8709377

RESUMO

PURPOSE: A deficient urethral segment was replaced with penile skin during a 1-stage procedure in patients with a long, tight urethral stricture, multiple attempts at hypospadias repair or severe hypospadias and circumcision. MATERIALS AND METHODS: In 29 patients a pedicled circumferential strip of distal penile skin was used to construct a neourethral floor. The roof was formed by regeneration of the epithelium from the edges of the floor over Buck's fascia. In our series the urethra was reconstructed because of an anterior urethral stricture in 11 patients, multiple failed hypospadias repairs in 6 and severe hypospadias with circumcision in 12. RESULTS: A neourethra of sufficient caliber and length was constructed with minimal postoperative complications in all patients. There were 2 cases of urethrocutaneous fistula at the subcoronal region, 1 meatal stenosis, 1 persistent chordee and 1 small distal penile skin patch slough that required only prolonged dressings. Mean followup was 19 months. CONCLUSIONS: Our urethroplasty technique can be used to correct various types of anterior urethral stricture or hypospadias associated with insufficient penile or preputial skin.


Assuntos
Hipospadia/cirurgia , Retalhos Cirúrgicos/métodos , Uretra/cirurgia , Estreitamento Uretral/cirurgia , Adolescente , Adulto , Criança , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Pênis
13.
Clin Exp Pharmacol Physiol ; 13(2): 113-21, 1986 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3754795

RESUMO

Monensin was given orally to female rats at two dose levels (1.75 and 3.50 mg/kg body weight) over the period of 9-17 days of pregnancy where organogenesis of fetuses occur. The dams were killed on the nineteenth day of gestation and their fetuses were subjected to morphological, visceral and skeletal examination. The small dose of monensin increased the number of resorbed and dead fetuses and induced marked retardation in growth of viable fetuses, but visceral or skeletal defects in these fetuses were not seen. Large doses produced fetal resorption in all dams and no viable fetuses were delivered. Prolonged oral administration of monensin in male rats for 60 successive days at two dose levels, decreased the conception rate in non-treated females (mated with treated males) to 33.3% and 0% for the small and large doses, respectively. Both doses markedly decreased the weights of testicles, epididymides and seminal vesicles. The small dose of monensin caused oligospermia, whereas the large dose induced azospermia. Both doses decreased the activity of spermatogenic epithelium and caused degeneration in germ cells after histopathological examination of the testicles. It is concluded that monensin given during pregnancy to female rats is fetotoxic and when administered chronically to male rats, causes damage to the reproductive organs. The delayed effects of this drug are especially prominent.


Assuntos
Fertilidade/efeitos dos fármacos , Doenças Fetais/induzido quimicamente , Furanos/toxicidade , Infertilidade Feminina/induzido quimicamente , Infertilidade Masculina/induzido quimicamente , Monensin/toxicidade , Anormalidades Induzidas por Medicamentos , Animais , Feminino , Morte Fetal/induzido quimicamente , Retardo do Crescimento Fetal/induzido quimicamente , Reabsorção do Feto/induzido quimicamente , Doenças dos Genitais Masculinos/induzido quimicamente , Masculino , Oligospermia/induzido quimicamente , Gravidez , Ratos
15.
Br Med J ; 3(5667): 394-6, 1969 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-5797782

RESUMO

Both in vitro and in vivo, aspirin inhibited the adenosine diphosphate and collagen-induced release of platelet factor 4 (antiheparin factor). The release induced by adrenaline and thrombin was not affected. The in-vivo effect in normal persons lasted for at least three days. Platelet uptake of acetyl-(14)C-aspirin was significantly greater than that of carboxyl-(14)C-aspirin.


Assuntos
Aspirina/farmacologia , Fatores de Coagulação Sanguínea/metabolismo , Plaquetas/efeitos dos fármacos , Cálcio , Nucleotídeos de Adenina , Aspirina/metabolismo , Testes de Coagulação Sanguínea , Plaquetas/metabolismo , Isótopos de Carbono , Colágeno , Epinefrina , Humanos , Técnicas In Vitro , Trombina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA